Does Abciximab Promote Coronary Artery Remodeling in Patients With Kawasaki Disease?

American Journal of Cardiology

Volumn 105, Issue 11, 2010, Pages 1625-1628

  McCandless, Rachel T ^a   Minich, L LuAnn ^a   Tani, Lloyd Y ^a   Williams, Richard V ^a  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

ACUTE HEART INFARCTION; AGE; ANGIOGENESIS; ARTERY DIAMETER; ARTICLE; BLEEDING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DEATH; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LOADING DRUG DOSE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OFF LABEL DRUG USE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; SINGLE DRUG DOSE; TIME; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ASPIRIN; CHILD; CHILD, PRESCHOOL; CORONARY VESSELS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULINS; INFANT; MALE; MEDICAL RECORDS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77952428455     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.332     Document Type: Article

References (16)

1. Taubert K.A., Rowley A.H., and Shulman S.T. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 119 (1991) 279-282
2. Kato H., Sugimura T., Akagi T., Sato N., Hashino K., Maeno Y., Kazue T., Eto G., and Yamakawa R. Long-term consequences of Kawasaki disease: a 10 to 21-year follow-up study of 594 patients. Circulation 94 (1996) 1379-1385
3. Dajani A.S., Taubert K.A., Gerber M.A., Shulman S.T., Ferrieri P., Freed M., Takahashi M., Bierman F.Z., Karchmer A.W., and Wilson W. Diagnosis and therapy of Kawasaki disease in children. Circulation 87 (1993) 1776-1780
4. Newburger J.W., Takahashi M., Gerber M.A., Gewitz M.H., Tani L.Y., Burns J.C., Shulman S.T., Bolger A.F., Ferrieri P., Baltimore R.S., Wilson W.R., Baddour L.M., Levison M.E., Pallasch T.J., Falace D.A., and Taubert K.A. Diagnosis, treatment, and Long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110 (2004) 2747-2771
5. Newburger J.W., Takahashi M., Burns J.C., Beiser A.S., Chung K.J., Duffy C.E., Glode M.P., Mason W.H., Reddy V., and Sanders S.P. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315 (1986) 341-347
6. Newburger J.W., Takahashi M., Beiser A.S., Burns J.C., Bastian J., Chung K.J., Colan S.D., Duffy C.E., Fulton D.R., Glode M.P., Mason W.H., Meissner H.C., Rowley A.H., Shulman S.T., Reddy V., Sundel R.P., Wiggin J.W., Colton T.C., Melish M.E., and Rosen F.S. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324 (1991) 1633-1639
7. Suzuki A., Kamiya T., Arakaki Y., Kinoshita Y., and Kimura K. Fate of coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 74 (1994) 822-824
8. Minich L.L., Tani L.Y., Pagotto L.T., Young P.C., Etheridge S.P., and Shaddy R.E. Usefulness of echocardiography for detection of coronary artery thrombi in patients with Kawasaki disease. Am J Cardiol 82 (1998) 1143-1146 A10
9. Foster R.H., and Wiseman L.R. Abciximab: an updated review of its use in ischaemic heart disease. Drugs 56 (1998) 629 -265
10. Rakowski T., Mielecki W., Brzozowska-Czarnek A., Dziewierz A., Siudak Z., Legutko J., Rzeszutko L., Urbanik A., Dubiel J.S., and Dudek D. Effects of early abciximab administration before primary percutaneous coronary intervention on left ventricular function assessed by cardiac magnetic resonance. Kardiol Pol 66 (2008) 617-622
11. Williams R.V., Wilke V.M., Tani L.Y., and Minich L.L. Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?. Pediatrics 109 (2002) E4
12. Akiba T., Sato T., Yoshikawa M., Otaki S., Kobayashi Y., Nakasato M., Suzuki H., and Hayashi T. Prognostic significance of the size of coronary artery aneurysms in Kawasaki disease. Acta Paediatr Jpn 31 (1989) 7-11
13. Nakano H., Ueda K., Saito A., and Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 56 (1985) 846-851
14. Etheridge S.P., Tani L.Y., Minich L.L., and Revenaugh J.R. Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease. Cathet Cardiovasc Diagn 45 (1998) 264-268
15. Dhillon R., Clarkson P., Donald A.E., Powe A.J., Nash M., Novelli V., Dillon M.J., and Deanfield J.E. Endothelial dysfunction late after Kawasaki disease. Circulation 94 (1996) 2103-2106
16. Hamaoka K., Onouchi Z., Kamiya Y., and Sakata K. Evaluation of coronary flow velocity dynamics and flow reserve in patients with Kawasaki disease by means of a Doppler guide wire. J Am Coll Cardiol 31 (1998) 833-840